<DOC>
	<DOCNO>NCT00882245</DOCNO>
	<brief_summary>Atopic Dermatitis chronic inflammatory skin disease affect 10 15 % child 2 10 % adult . AD characterise itchy skin eruption may cover large part body . The exact cause unknown think interplay genetic environmental factor . The objective study determine whether SRD441 ointment safe effective therapy mild moderate Atopic Dermatitis .</brief_summary>
	<brief_title>Safety Efficacy SRD441 Ointment Patients With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Male female subject age 18 Subjects history AD Written date informed consent Satisfactory medical assessment clinical relevant abnormality . Subjects current recurrent disease ( except AD ) could affect site application , action , absorption disposition investigational product , clinical laboratory assessment . Subjects medical psychiatric condition laboratory abnormality may increase risk associate trial participation investigational product administration may interfere interpretation trial result , judgement investigator , would make subject inappropriate entry trial . Subjects skin tattoo , scar , cut , bruise , skin damage , include excessive UV exposure , possible drug application site could impact application test agent confound local assessment study . Subjects clinically significant renal liver parameter , define great 1.5 x creatinine 3 x AST ULN ( upper limit normal ) respectively .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>